SIGNAL-AVERAGED ELECTROCARDIOGRAPHY, QT-DISPERSION, AND DOPPLER-ECHOCARDIOGRAPHY IN THE EVALUATION OF MYOCARDIAL INVOLVEMENT IN PROGRESSIVESYSTEMIC-SCLEROSIS
F. Gabrielli et al., SIGNAL-AVERAGED ELECTROCARDIOGRAPHY, QT-DISPERSION, AND DOPPLER-ECHOCARDIOGRAPHY IN THE EVALUATION OF MYOCARDIAL INVOLVEMENT IN PROGRESSIVESYSTEMIC-SCLEROSIS, Journal of cardiovascular diagnosis and procedures, 15(2), 1998, pp. 85-89
Citations number
20
Categorie Soggetti
Radiology,Nuclear Medicine & Medical Imaging","Cardiac & Cardiovascular System
To assess the myocardial involvement in Progressive Systemic Sclerosis
(PSS), we evaluated the presence of late potentials (LP) by signal-av
eraged electrocardiography (SAECG), QT-dispersion (QTD) by standard EG
G, and the ventricular function by echocardiography. Fifteen outpatien
ts, 7 with diffuse PSS (dPSS) and 8 with CREST syndrome variant, witho
ut clinical and electrocardiographic evidence of cardiac disease, were
studied and compared with 18 normal subjects. LP in PSS occurred in 5
out of 15 patients (33%) vs 1 out of 18 controls (5.5%) with signific
ant difference (p < 0.05). LP were present in 5 of 7 patients with dPS
S (71.4%, p < 0.001 vs controls). By contrast none of patients with CR
EST syndrome showed LP. The QTD duration in all PSS patients was highe
r than in control subjects (34.01 +/- 14.87 vs 26.61 +/- 10.29), and i
n the dPSS patients was found a significant increased QTD duration (42
.0 +/- 17.87; p < 0.001 vs controls). Abnormalities of left ventricula
r filling dynamic were found in 9 PSS patients (5 with dPSS and 4 with
CREST; p < 0.001), and dPSS subgroup showed lower values of E/A, E in
tegral/A integral and EF slope and higher values of IVRT in comparison
with the CREST subgroup. We found that the more altered left ventricu
lar diastolic function was frequently found in patients with dPSS than
in CREST patients. Besides, the presence of LP and higher duration of
QTD in dPSS subgroup could be a marker of increased arrhythmic risk r
elated to a more advanced myocardial fibrosis.